106 related articles for article (PubMed ID: 26501171)
21. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
[TBL] [Abstract][Full Text] [Related]
22. NMDA receptor-dependent processes in the medial prefrontal cortex are important for acquisition and the early stage of consolidation during trace, but not delay eyeblink conditioning.
Takehara-Nishiuchi K; Kawahara S; Kirino Y
Learn Mem; 2005; 12(6):606-14. PubMed ID: 16322362
[TBL] [Abstract][Full Text] [Related]
23. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.
Chen X; McClatchy DB; Geller EB; Tallarida RJ; Adler MW
Life Sci; 2005 Dec; 78(4):329-33. PubMed ID: 16257420
[TBL] [Abstract][Full Text] [Related]
24. Connections of the caudal anterior cingulate cortex in rabbit: neural circuitry participating in the acquisition of trace eyeblink conditioning.
Weible AP; Weiss C; Disterhoft JF
Neuroscience; 2007 Mar; 145(1):288-302. PubMed ID: 17224240
[TBL] [Abstract][Full Text] [Related]
25. Effect of norbinaltorphimine on ∆⁹-tetrahydrocannabinol (THC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats.
Flax SM; Wakeford AG; Cheng K; Rice KC; Riley AL
Psychopharmacology (Berl); 2015 Sep; 232(17):3193-201. PubMed ID: 26025420
[TBL] [Abstract][Full Text] [Related]
26. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
[TBL] [Abstract][Full Text] [Related]
27. Morphine upregulates kappa-opioid receptors of human lymphocytes.
Suzuki S; Chuang TK; Chuang LF; Doi RH; Chuang RY
Adv Exp Med Biol; 2001; 493():81-7. PubMed ID: 11727785
[TBL] [Abstract][Full Text] [Related]
28. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
Kelsey JE; Verhaak AM; Schierberl KC
Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
[TBL] [Abstract][Full Text] [Related]
29. Neurotransmitter release during delay eyeblink classical conditioning: role of norepinephrine in consolidation and effect of age.
Paredes DA; Cartford MC; Catlow BJ; Samec A; Avilas M; George A; Schlunck A; Small B; Bickford PC
Neurobiol Learn Mem; 2009 Oct; 92(3):267-82. PubMed ID: 18809505
[TBL] [Abstract][Full Text] [Related]
30. Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala.
Kang-Park M; Kieffer BL; Roberts AJ; Siggins GR; Moore SD
J Pharmacol Exp Ther; 2015 Nov; 355(2):206-11. PubMed ID: 26350161
[TBL] [Abstract][Full Text] [Related]
31. Sustained Activity of Hippocampal Parvalbumin-Expressing Interneurons Supports Trace Eyeblink Conditioning in Mice.
Li R; Zhang W; Zhang J; Zhang H; Chen H; Hu Z; Yao Z; Chen H; Hu B
J Neurosci; 2022 Nov; 42(44):8343-8360. PubMed ID: 36167784
[TBL] [Abstract][Full Text] [Related]
32. N-methyl-D-aspartate receptors play important roles in acquisition and expression of the eyeblink conditioned response in glutamate receptor subunit delta2 mutant mice.
Kato Y; Takatsuki K; Kawahara S; Fukunaga S; Mori H; Mishina M; Kirino Y
Neuroscience; 2005; 135(4):1017-23. PubMed ID: 16165299
[TBL] [Abstract][Full Text] [Related]
33. The neural circuitry and molecular mechanisms underlying delay and trace eyeblink conditioning in mice.
Yang Y; Lei C; Feng H; Sui JF
Behav Brain Res; 2015 Feb; 278():307-14. PubMed ID: 25448430
[TBL] [Abstract][Full Text] [Related]
34. A novel method for precisely timed stimulation of mouse whiskers in a freely moving preparation: application for delivery of the conditioned stimulus in trace eyeblink conditioning.
Galvez R; Weiss C; Cua S; Disterhoft J
J Neurosci Methods; 2009 Mar; 177(2):434-9. PubMed ID: 19041891
[TBL] [Abstract][Full Text] [Related]
35. Ventral hippocampal kappa opioid receptors mediate the renewal of fear following extinction in the rat.
Cole S; Richardson R; McNally GP
PLoS One; 2013; 8(5):e58701. PubMed ID: 23675405
[TBL] [Abstract][Full Text] [Related]
36. Disrupted topography of the acquired trace-conditioned eyeblink responses in guinea pigs after suppression of cerebellar cortical inhibition to the interpositus nucleus.
Hu B; Chen H; Feng H; Zeng Y; Yang L; Fan ZL; Wu YM; Sui JF
Brain Res; 2010 Jun; 1337():41-55. PubMed ID: 20381463
[TBL] [Abstract][Full Text] [Related]
37. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist.
Chauvignac C; Miller CN; Srivastava SK; Lewis JW; Husbands SM; Traynor JR
J Med Chem; 2005 Mar; 48(5):1676-9. PubMed ID: 15743210
[TBL] [Abstract][Full Text] [Related]
38. Antagonism of the kappa opioid receptor attenuates THC-induced place aversions in adult male Sprague-Dawley rats.
Clasen MM; Flax SM; Hempel BJ; Cheng K; Rice KC; Riley AL
Pharmacol Biochem Behav; 2017 Dec; 163():30-35. PubMed ID: 29100992
[TBL] [Abstract][Full Text] [Related]
39. Spine loss in primary somatosensory cortex during trace eyeblink conditioning.
Joachimsthaler B; Brugger D; Skodras A; Schwarz C
J Neurosci; 2015 Mar; 35(9):3772-81. PubMed ID: 25740508
[TBL] [Abstract][Full Text] [Related]
40. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
Wang D; Sun X; Sadee W
J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
